| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.1 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |